Observational studyMedicine2025
Hospitalization linked to antiepileptics, sedative-hypnotics and anti-Parkinsonian drug poisoning, adverse effects, and underdosing in Australia: An ecological study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Poisoning from medications such as antiepileptics, sedative-hypnotics and anti-Parkinsonian drugs remains a major public health concern. These medications contribute significantly to death and illness from intentional or accidental overdose. In Australia, these medications are associated with high rates of hospital admissions. Our study aimed to analyze trends in hospital admissions related to poisoning from antiepileptics, sedative-hypnotics and anti-Parkinsonian drugs in Australia for 24 years, starting from 1998. We collected hospital admission data for poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonian drugs from the National Hospital Disease Database. Population data were obtained from the Australian Bureau of Statistics. We analyzed based on total trends, type of admission, age, gender, and medication category. A total of 202,705 hospital admission episodes due to poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonian drugs were recorded in Australia during the study time, with a decreased hospital admissions number and hospital rate of 41.7% and 57.8%, respectively. Overnight-stay admissions accounted for 69.4% of the total admissions. The primary cause of hospital admissions was poisoning by benzodiazepines. Admissions were highest among the age groups 20 to 59 and females. The study demonstrated a substantial decline in hospital admissions for poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonian drugs in Australia. Still, hospital admission rates increased for certain drug classes. Some population groups were at higher risk of hospital admission. These findings suggest the need for continued monitoring, targeted interventions, and increased awareness among the population to reduce drug poisoning and related hospital admissions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.